Stocks

Stock Market News

20 stories
tradingview

Weekly Recap: Levi Q2 2026 earnings and J.P. Morgan price target raise

Levi Strauss & Co. Class A (NYSE:LEVI) will report Q2 2026 results July 8, including revenue, EPS, same‑store sales and guidance tied to apparel demand and consumer spending; J.P. Morgan keeps an Overweight rating and raised its price target to $32.00.Previous Week Recap This is an AI-g…

TradingView en
StocksUS
tradingview

Weekly Recap: Lucid executive reshuffle and Uber‑Nuro robotaxi supplier

Lucid Group (NASDAQ:LCID) reshuffled its leadership—Alexander De Bock named CFO while Taoufiq Boussaid stays through Q2 2026 to transition and several senior execs were reassigned—as the company positions itself as sole vehicle supplier for Uber and Nuro’s 35,000 Gravity robotaxi rollout starting S…

TradingView en
StocksUS
tradingview

Weekly Recap: MK-1167 trial halted and Q2 earnings call Aug 4

Merck & Co. (NYSE:MRK) said it halted a mid‑stage trial of MK‑1167 for mild‑to‑moderate Alzheimer’s after enrolling about 350 patients and closed the study in June for business reasons with no safety concerns, while analysts remain bullish ahead of its Aug. 4 Q2 earnings call.Previous Week Recap…

TradingView en
StocksUS
tradingview

Weekly Recap: NASA contract up to $148.3M and Artemis lunar lander role

Intuitive Machines, Inc. Class A (NASDAQ:LUNR) surged after winning a NASA contract—$68.6M base, up to $148.3M with incentives—to deliver the Nova‑C uncrewed lunar lander for Artemis by late 2028, highlighting the company’s growing role in lunar delivery services and stirring trader interest.Previo…

TradingView en
StocksUS
tradingview

Weekly Recap: NBCUniversal and Sky spin-off and media-broadband split

Comcast Corporation Class A (NASDAQ:CMCSA) surged after unveiling a tax-free spin-off of NBCUniversal and Sky into a separate media unit — with Comcast possibly retaining up to 19.9% — while Deutsche Bank upgraded the stock and the company backed the Trump Accounts children’s savings program.Previo…

TradingView en
StocksUS
tradingview

Weekly Recap: New $1.5B & $1.25B revolvers and Pacira iovera buy for $140M

Zimmer Biomet (NYSE:ZBH) strengthened liquidity with new revolvers while acquiring Pacira’s iovera pain‑relief business for up to $140M and announcing a Bengaluru tech center that will hire 500 staff over three years, aligning funding, M&A and talent for growth.Previous Week Recap This…

TradingView en
StocksUS
tradingview

Weekly Recap: New SMG CEO and chair and Halper Sadeh probe of SMG insiders

Scotts Miracle‑Gro Company (NYSE:SMG) promoted Nate Baxter to CEO with Pete Shumlin as chair while reaffirming EPS and modest U.S. sales growth, accelerating a digital pivot toward Amazon, Walmart and TikTok Shop as activists probe insiders for potential fiduciary breaches.Previous Week Recap…

TradingView en
StocksUS
tradingview

Weekly Recap: Newmont Q2 2026 results and Red Chris feasibility, CAD 500M

Newmont Corporation (NYSE:NEM) will report Q2 2026 results after market close July 23 and host a 5:30 p.m. EDT earnings call with a webcast replay; the company is also a JV partner in Imperial Metals’ Red Chris Block Cave project, now in definitive feasibility toward a final investment decision bac…

TradingView en
StocksUS
tradingview

Weekly Recap: NextEra takeover of Dominion and Sen. King urges FERC block

NextEra Energy’s announced $66.8B merger to acquire Dominion Energy (NYSE:D) would create a massive combined utility, drawing political pushback as Sen. Angus King urged FERC to block the deal over concerns it would consolidate power and reduce competition across Dominion’s 10M+ customers.Previous…

TradingView en
StocksUS
tradingview

Weekly Recap: Nippon Dry-Chemical tender and Carlyle $400M India IPO

Carlyle Group (NASDAQ:CG) and partner ALSOK completed a tender offer for Nippon Dry-Chemical after 14,162,145 shares were tendered, as Carlyle simultaneously explores growth options—reportedly hiring JM Financial and Goldman Sachs to advise a possible $400M IPO in India for its healthcare RCM unit…

TradingView en
StocksUS
tradingview

Weekly Recap: Optune Pax CE mark and Q2 2026 results date

NovoCure Ltd. (NASDAQ:NVCR) won CE mark for its Optune Pax in adults with locally advanced pancreatic cancer after PANOVA‑3 showed a median OS 16.2 vs 14.2 months (HR 0.82, p=0.039) and longer pain control with mainly mild skin AEs; the company will report Q2 2026 results July 23 before US open and…

TradingView en
StocksUS
tradingview

Weekly Recap: Orladeyo pellets cleared and guidance kept, expenses cut

BioCryst Pharmaceuticals (NASDAQ:BCRX) resolved a pediatric Orladeyo manufacturing delay with pellets due early August while preserving FY revenue guidance and trimming 2026 operating expense outlook as it winds down Birmingham; Cantor raised its price target and the company granted inducement equi…

TradingView en
StocksUS
tradingview

Weekly Recap: PH-HFpEF Phase 3 Enrollment Complete and Stock Options Granted

Tenax Therapeutics (NASDAQ:TENX) has completed Phase 3 enrollment for oral levosimendan (TNX‑103) in PH‑HFpEF and is prepping a database lock and analysis ahead of expected August 2026 topline results, while issuing 160,000 inducement options to three non‑executive hires.Previous Week Recap…

TradingView en
StocksUS
tradingview

Weekly Recap: PTEN Q1 revenue decline and Citigroup keeps Neutral, cuts PT

Patterson-UTI Energy (NASDAQ:PTEN) reported Q1 revenue of $1.12B, down 12.7% YoY, but topped earnings and EBITDA estimates; despite the beat, the stock has slid about 19.9% to near $8.66 and Citigroup kept a Neutral rating while trimming its target to $10.50.Previous Week Recap This is…

TradingView en
StocksUS
tradingview

Weekly Recap: Parsons Q2 2026 earnings call and PFAS remediation expansion

Parsons Corporation (NYSE:PSN) readies Q2 results and a July 29 call as it expands PFAS remediation across the U.S. and Canada, joins Raft’s Indo‑Pacific AI/data partner program after military trainings, and eyes an $80M consultancy bid for Qatar’s new Foreign Affairs Complex.Previous Week Recap…

TradingView en
StocksUS
tradingview

Weekly Recap: Pro‑forma $8.1B revenue, $1.0B EBITDA and $94.2M breakup fee

LCI Industries (NYSE:LCII) said a proposed combination would create a pro forma company with about $8.1B in trailing revenue, ~$1.0B adjusted EBITDA, $508M free cash flow and over $150M run‑rate synergies within three years, while an SEC filing notes a $94.2M breakup fee to Patrick Industries if th…

TradingView en
StocksUS
tradingview

Weekly Recap: PureSAF 100ktpy Jurong plant and Q2 2026 results

KBR, Inc. (NYSE:KBR) said it will license PureSAF technology and provide engineering for a proposed 100,000 tpy SAF plant on Singapore’s Jurong Island—news that lifted its shares—while the company prepares to publish Q2 2026 results and a presentation ahead of its July 30 conference call.Previous W…

TradingView en
StocksUS
tradingview

Weekly Recap: Q1 financial miss and Thymmune acquisition for up to $300M

United Therapeutics (NASDAQ:UTHR) reported modestly weaker Q1 results—$781.5M revenue, down 1.6% YoY, and EPS missing estimates—sending the stock lower, while the company moved to bolster its pipeline by agreeing to acquire Thymmune for up to $300M to advance iPSC-derived thymic therapy THY-100.Pre…

TradingView en
StocksUS
tradingview

Weekly Recap: Q1 revenue beat, shares up and Q2 results date investor call

Republic Services, Inc. (NYSE:RSG) posted a strong Q1 with $4.11B revenue, adjusted operating income beating estimates and CEO calling it a strong start, lifting shares about 5.5% near $212.66; the company will report Q2 on Aug 6 with a 5:00 p.m. ET investor webcast.Previous Week Recap…

TradingView en
StocksUS
tradingview

Weekly Recap: Q1 revenue flat, guidance miss and Rebel Daughter launch

Under Armour (NYSE:UA) reported flat Q1 revenue of $1.17B, met sales estimates but missed full-year EPS and adjusted operating income as CEO cites a business reset; shares rose modestly on the results and on plans to launch Rebel Daughter womenswear by Feng Chen Wang in Q4 2026.Previous Week Recap…

TradingView en
StocksUS